Interview with prof. Jakub Żołnierek from the National Institute of Oncology.
Prof. Jakub Żołnierek said, among others:
- We do not have access to modern hormonal drugs, which until recently could be used in the reimbursed option at the stage of castration resistance with dissemination.
- For several months now,...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
